Naoaki Hori

Clinical Assessment and Mutation Analysis of Kallmann Syndrome 1 (<i>KAL1</i>) and Fibroblast Growth Factor Receptor 1 (<i>FGFR1</i>, or<i>KAL2</i>) in Five Families and 18 Sporadic Patients

Naoko Sato, Noriyuki Katsumata, Masayo Kagami et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 219 citations · Full text

Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study

Koichi Miyata, Tetsuji Kaneko, Yoshihiko Morikawa et al. · The Lancet Child & Adolescent Health · 2018 · 94 citations

Rheumatology, Post Raise, Autoimmune Disease +7

Functional heterogeneity of rat liver macrophages: interleukin‐1 secretion and Ia antigen expression in contrast with phagocytic activity

Yoshito Itoh, Takeshi Okanoue, Masahiro Morimoto et al. · Liver International · 1992 · 39 citations

Risk Factors of Coronary Artery Abnormalities and Resistance to Intravenous Immunoglobulin Plus Corticosteroid Therapy in Severe Kawasaki Disease

Koichi Miyata, Masaru Miura, Tetsuji Kaneko et al. · Circulation Cardiovascular Quality and Outcomes · 2021 · 31 citations

Functional characterization of four novel PAX8 mutations causing congenital hypothyroidism: new evidence for haploinsufficiency as a disease mechanism

Satoshi Narumi, Shunsuke Araki, Naoaki Hori et al. · European Journal of Endocrinology · 2012 · 30 citations